Mitsubishi UFJ Asset Management
RVMD icon

Mitsubishi UFJ Asset Management’s Revolution Medicines RVMD Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35M Buy
186,924
+21,936
+13% +$3.2M 0.02% 458
2026
Q1 		$16M Buy
164,988
+133,474
+424% +$13.5M 0.01% 542
2025
Q4 		$2.49M Hold
31,514
– – ﹤0.01% 719
2025
Q3 		$1.47M Hold
31,514
– – ﹤0.01% 762
2025
Q2 		$1.16M Hold
31,514
– – ﹤0.01% 776
2025
Q1 		$1.11M Hold
31,514
– – ﹤0.01% 782
2024
Q4 		$1.39M Hold
31,514
– – ﹤0.01% 777
2024
Q3 		$1.43M Buy
+31,514
New +$1.37M ﹤0.01% 768

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Mitsubishi UFJ Asset Management's RVMD Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Revolution Medicines (RVMD) stake by 13% in Q2 2026, buying an estimated $3.2M and bringing the position to 186,924 shares worth $35M. The position accounts for 0.02% of the portfolio, ranked #458.

Mitsubishi UFJ Asset Management first reported a position in RVMD in Q3 2024 and has held it in 8 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 186,924 shares of Revolution Medicines worth $35M as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 21,936 Revolution Medicines shares in Q2 2026, an estimated $3.2M.
  • Revolution Medicines made up 0.02% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #458 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Revolution Medicines in Q3 2024 and has held it in 8 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.